OHSS or ovarian hyperstimulation syndrome is a medical condition which sometimes occurs due to hormonal medicaments which are designed for the stimulation of the development of eggs in the ovaries. These medicaments usually come in the form of injections and they are commonly used for the treatment of infertility. OHSS is a medical condition which unfortunately involves swelling and painful sensations in the ovaries. This condition usually affects every fourth woman who takes fertility injections, and it does not last for more than a week. If a woman becomes pregnant, the condition may last longer and in some cases it may last up to several weeks. Some rare cases may involve severe form of OHSS which is characterized by shortness of breath, vomiting, abdominal pain and rapid weight gain.
Most cases of OHSS begin after 10 days of taking the fertility medication. The symptoms may vary from person to person. Moderate instances of OHSS can be characterized by tenderness in the area of the ovaries, diarrhea, vomiting, nausea, increased girth, abdominal bloating and reoccurring mild to moderate abdominal pain. Severe cases of OHSS can be characterized by dizziness, enlarged abdomen, tight abdomen, shortness of breath, dark urine, decreased urinary frequency, vomiting, severe nausea and severe abdominal pain. Women who suffer from severe OHSS usually experience a very rapid weight gain. If a person experiences any of the aforementioned symptoms of the ovarian hyperstimulation syndrome, she should visit the doctor.
Ovarian hyperstimulation syndrome occurs after taking fertility medications which are designed to enhance the production of the eggs. Oral medications such as clomiphene which are used for the same purposes are usually not involved with the occurrence of ovarian hyperstimulation syndrome. These medicaments are much easier to take and are commonly much cheaper than the aforementioned injectible types of medications. The medications which are commonly associated with the occurrence and development of ovarian hyperstimulation syndrome include human chorionic gonadotropin, human menopausal gonadotropin, luteinizing hormone and follicle stimulating hormone.
There are certain individualized plans for fertility medications which can be of great help in reducing the risk and preventing OHSS from occurring. A wide variety of strategies used for the prevention of ovarian hyperstimulation syndrome include follicle aspiration and freezing of embryos, avoiding the use of the already mentioned human chorionic gonadotropin, coasting and adjusting the dosage of medications. It is strongly suggested to always use the lowest doses of gonadotropin possible.